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In the developing vertebrate embryo, proper dorsal–ventral patterning relies on BMP antagonists secreted by the organizer during gastrulation.
The BMP antagonist chordin has a complex interaction with BMPs that is governed in part by its interaction with the secreted protein twisted
gastrulation (tsg). In different contexts, tsg has activity as either a BMP agonist or as a BMP antagonist. Using morpholino oligonucleotides in
Xenopus tropicalis, we show that reducing tsg gene product results in a ventralized embryo, and that tsg morphants specifically lack a forebrain.
We provide new evidence that tsg acts as a BMP antagonist during X. tropicalis gastrulation since the tsg depletion phenotype can be rescued in
two ways: by chordin overexpression and by BMP depletion. We conclude that tsg acts as a BMP antagonist in the context of the frog gastrula,
and that it acts cooperatively with chordin to establish dorsal structures and particularly forebrain tissue during development.
D 2005 Elsevier Inc. All rights reserved.Keywords: Twisted gastrulation; BMP antagonist; Chordin; Forebrain; Xenopus tropicalis; Morpholino oligonucleotidesIntroduction
During early development in the Xenopus embryo, bone
morphogenetic protein (BMP) signaling plays a major role in
the specification of the dorsal–ventral axis (De Robertis et al.,
2000; Harland, 2004; Harland and Gerhart, 1997; Niehrs,
2004). Transduction of BMP signals promotes ventralization
and suppresses the formation of dorsal structures such as neural
tissue, somites and notochord. Thus, dorsal development
requires suppression of BMP signaling. In the gastrulating
frog embryo, BMP antagonists are secreted by Spemann’s
Organizer and sequester BMPs from their target receptors. In
the absence of secreted BMP antagonists, the embryo fails to
form dorsal structures or neural tissue, demonstrating that BMP
antagonism is required for these cell fates (Khokha et al.,
2005).
Several BMP antagonists have been characterized, including
noggin, chordin, follistatin, Xnr3 and the multifunctional
antagonist cerberus (De Robertis et al., 2000; Harland and0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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these molecules results in the formation of secondary axes,
where presumptive ventrolateral tissues develop with dorsal
cell fates. Conversely, loss of BMP antagonists results in
mispatterning of the embryo and a loss of dorso-anterior
structures. For example, zebrafish embryos with null mutations
in chordin are partially ventralized, while mice that are mutant
for noggin and chordin have defects in anterior head formation
(Bachiller et al., 2000; Schulte-Merker et al., 1997). Frog
embryos depleted of chordin, noggin and follistatin completely
fail to develop dorsal structures (Khokha et al., 2005).
While noggin, chordin, cerberus and perhaps follistatin all
exert their antagonistic effects by binding directly to BMPs, the
interaction between chordin and BMPs is particularly complex.
Chordin binds BMP4 and BMP7 with high affinity, and
prevents binding of BMP ligands to their cognate receptors,
thus interfering with BMP signaling (Piccolo et al., 1996).
Biochemical studies demonstrate that three cysteine-rich
domains in the chordin protein bind BMPs (Garcia Abreu
et al., 2002; Larrain et al., 2000). These individual domains
will also bind BMPs following cleavage of chordin, albeit
with lesser affinity than full-length chordin. Cleavage of
chordin is mediated by the metalloproteinase xolloid (tolloid89 (2006) 166 – 178
www.e
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BMP complexes (Piccolo et al., 1997).
The interaction between chordin, xolloid and BMPs is
modulated by another secreted protein, twisted gastrulation
(tsg) (Chang et al., 2001; Oelgeschlager et al., 2000; Scott et
al., 2001). In vertebrates, tsg binds both chordin and BMP with
high affinity, forming ternary complexes. Based on the
biochemical data, the interaction of chordin with BMPs can
favor roles for tsg as either a BMP agonist or BMP antagonist.
One study has proposed that tsg can act as both a BMP agonist
and antagonist depending on the cleavage state of chordin
(Larrain et al., 2001). According to this model, tsg promotes
chordin function by enhancing the binding of chordin to BMP,
forming stable ternary complexes and preventing BMP
signaling (Scott et al., 2001). However, tsg/BMP/chordin
complexes would also represent a superior substrate for
cleavage of chordin by xolloid, lowering chordin’s affinity
for BMP and consequently promoting BMP signaling. Thus, a
balance of BMP agonist/antagonist activity could be mediated
by tsg according to the relative abundance of xolloid and
chordin-bound BMP. In addition, the pro-BMP activity of tsg
may be independent of BMP binding, again emphasizing its
interactions with chordin (Oelgeschlager et al., 2003b).
In vivo evidence for the activity of twisted gastrulation in
vertebrates has also been used to support a model of either
BMP agonism or antagonism. Overexpression studies of tsg in
zebrafish and in Xenopus have given seemingly contradictory
results. In zebrafish, overexpression of tsg results in dorsalized
embryos (Little and Mullins, 2004; Ross et al., 2001). Reported
phenotypes of tailbud-stage Xenopus embryos injected with tsg
mRNA vary from dorsalized to ventralized (Chang et al., 2001;
Oelgeschlager et al., 2000; Scott et al., 2001). Microinjection
of high concentrations of tsg mRNA inhibits the ability of
injected chordin or its cleavage products to form secondary
axes (Oelgeschlager et al., 2000). However, lower concentra-
tions of tsg mRNA promote secondary axis formation by
chordin (Scott et al., 2001) and induce ectodermal tissues to
express dorsal rather than ventral markers (Chang et al., 2001).
Studies exploring the role of tsg by loss of function have led
to similarly complex inferences. Genetic knockouts of twisted
gastrulation (twsg in mammals) in the mouse lead to
thymocyte defects that are consistent with a role in BMP
antagonism, but also to bone defects that are more readily
explained by a role as a BMP agonist (Nosaka et al., 2003). In
some genetic backgrounds, loss of twsg is also accompanied by
severe craniofacial and forebrain defects (Petryk et al., 2004).
However, in most genetic backgrounds, twsg has no forebrain
defects. Compound twsg mutant/BMP4 heterozygotes exhibit
holoprosencephaly, while BMP7 homozygotes with one or
more mutant copies of twsg demonstrate sirenomelia, suggest-
ing that cooperative interactions may exist between tsg and
BMPs in the mouse (Zakin and De Robertis, 2004; Zakin et al.,
2005), though the diversity and the nature of the phenotypes
makes a straightforward interpretation of twsg function
difficult.
In Xenopus, loss-of-function analysis of chordin and tsg
using morpholino oligonucleotides (MOs) and rescue experi-ments with noggin and chordin demonstrated a cooperative role
between tsg and known BMP antagonists (Blitz et al., 2003). In
this study, depletion of tsg resulted in embryos with reduced
dorsal structures and expanded ventral structures, consistent
with reduced BMP antagonism. Recently, however, another
report in Xenopus indicated that depletion of tsg and BMP7 by
MOs resulted in a cooperative effect (Zakin et al., 2005).
In zebrafish, loss-of-function studies have also led to
complex conclusions. In an initial analysis, depletion of tsg
resulted in a reduction of dorsal structures, with sub-inhibitory
doses of chordin MO and tsg MO cooperating to expand
ventral tissues (Ross et al., 2001). In more recent studies (Little
and Mullins, 2004; Xie and Fisher, 2005), tsg depletion caused
an expansion in dorsal tissues and a reduction of ventral
tissues. In these experiments, sub-dorsalizing doses of tsg MO
dorsalized swirl (bmp2b) heterozygotes and mini-fin (tolloid)
mutants, indicating cooperation between tsg and BMPs. In
addition, tsg knockdown also partially appeared to suppress the
phenotypes seen in mutants of BMP antagonists.
Therefore in each of these model systems, articulating a
general role for tsg is difficult. Tsg appears to have an activity
that can either suppress or augment BMP signaling depending
on the developmental context in which it is characterized.
Therefore, in this study, we extended the previous analysis of
tsg by characterizing the molecular and morphological effects
of tsg loss of function in the diploid frog Xenopus tropicalis.
We have used MOs to deplete tsg, chordin, BMP4 and BMP7,
and have assayed the individual and combined effects of these
gene products on embryonic patterning. We have identified a
novel role for tsg in forebrain development in X. tropicalis and
provide new evidence that tsg acts as a BMP antagonist during
gastrulation.
Materials and methods
Ovulation, in vitro fertilization, and rearing of embryos
Ovulation of adult X. tropicalis (Nasco) and in vitro fertilization of eggs
were conducted as described (http://tropicalis.berkeley.edu/home). Fertilized
eggs were de-jellied in 3% cysteine in 1/9X modified frog ringer’s solution
(MR) for 10–15 min. Embryos were reared at room temperature (21–23-C) in
1/20X MR supplemented with 100 Ag/ml gentamicin sulfate.
Morpholino oligonucleotide design and injection
Morpholino oligonucleotides (MOs) were designed to block translation of
X. tropicalis tsg, chordin, BMP4 and BMP7 (Gene Tools, LLC). Sequences
were as follows: tsg MO 5VTAGGAGAGAGGGCTTCATACTTGGC3V; chor-
din MO 5 VCAAAGCATTTTTGTGGTAGCCCCGA3V; BMP4 MO
5VCCAGGAATCATGGTGTCTTGACAGA3V; BMP7 MO 5VTTACTATC-
AAAGCATTCATTTTGTC3V. MOs were resuspended in DEPC-treated 0.1 
MR to a concentration of either 1 mM or 2 mM. Fluorescent miniruby
(Molecular Probes, (Lane and Sheets, 2002)) was co-injected as a tracer for
injection. We injected both blastomeres at the two-cell stage (unless otherwise
stated), with each cell receiving half the total MO dose. For tsg MO, a total
dose of 5 ng/embryo is described as a ‘‘low dose’’, 10 ng/embryo is an
‘‘intermediate dose,’’ and 20 ng/embryo is a ‘‘high dose’’. For chordin MO, the
total dose was always 20 ng/embryo. For BMP 4 and BMP7, a total MO dose
of 20 ng/embryo is described as a ‘‘low dose’’ and a total dose of 40 ng/embryo
was described as a ‘‘high dose.’’ Co-injection of chordin and tsg MOs was
carried out at a total dose of 10 ng of tsg MO with 20 ng of chordin MO.
Fig. 1. Expression of tsg in X. tropicalis embryos. Embryos were collected a
the 2-cell stage (A), stage 8 (B), stage 9 (C) stage 10.5 (D) stage 11 (E), and
stage 22 (F), and assayed for expression of tsg. Panel A is a whole embryo
shown in lateral view with animal to the top, panels B, C are bisected embryos
shown with animal pole to the top. Panels D, E are bisected embryos shown
with animal to the top and dorsal to the right, and panel F is a whole embryo
shown laterally with anterior to the left.
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Because morphological criteria are used for staging and MO-injected embryos
sometimes did not develop with normal or complete morphology, control
embryos were used for staging, and then both control and injected embryos
were fixed concurrently. When possible, morphological criteria such as the
beginning of blastopore formation and the appearance of the cement gland, or
molecular criteria such as the onset of specific gene expression (described in
Results) were used to ensure that MO-injected embryos were not non-
specifically delayed in development.
mRNA injection
Template for chicken chordin (a generous gift of Paul Wilson) was
linearized with HindIII and transcribed using mMessage mMachine Sp6 RNA
polymerase kits (Ambion). Resulting RNA was resuspended in DEPC-treated
water. 50–100 pg were injected into the marginal zone of a single dorsal
blastomere at the 4 cell stage. Rainbow trout tsg (Oncorhynchus mykiss EST
tcay0033b.b.14, GenBank accession number BX317058) was subcloned into
CS107 using EcorI/NotI sites, then linearized for transcription with AscI and
transcribed as above. 200 pg of mRNA were injected into each dorsal
blastomere at the 4 cell stage. In both cases, mRNAs were co-injected with GFP
mRNA to allow tracing of the injection by fluorescence.
In situ hybridization
Clones were obtained from either the Sanger Center EST projects via the
HGMP MRC Geneservice, from the IMAGE clone libraries, or obtained by
PCR. Additional clone information as well as template preparation can be
obtained at http://tropicalis.berkeley.edu/home. In order to avoid trapping of
stain in the blastocoel cavity, blastula and some gastrula embryos were bisected
with a razor blade prior to dehydration.Results
Tsg Expression in X. tropicalis
We began our investigation of twisted gastrulation function
in X. tropicalis by examining its expression in early embryonic
stages. We find that tsg mRNA is detected in the animal portion
of cleavage-stage embryos (Fig. 1A), suggesting the presence
of maternal transcripts, as described for X. laevis (Oelges-
chlager et al., 2000). Tsg is expressed broadly through the
animal region at stage 8 (Fig. 1B), and is expressed
asymmetrically at stage 9 (Fig. 1C). By mid-gastrulation
(stages 10.5 and 11), we can no longer detect expression of
tsg (Figs. 1D, E), suggesting that gastrula-stage expression of
tsg in X. tropicalis may differ from X. laevis. However, we do
find that zygotic tsg is expressed in the tailbud region of early
tadpoles as is seen in X. laevis (stage 22, Figs. 1F, I) as well as
in the cement gland.
Tsg knockdown
A major goal in pursuing the function of tsg was to
determine the developmental effects of tsg knockdown using
morpholino oligonucleotides (MOs). We characterized the tsg
MO phenotype on the basis of morphological and molecular
data at several stages throughout development. Embryos
injected with a high dose of the tsg MO (10 ng per cell at
the two-cell stage) appear normal through blastula stages, and
initiate gastrulation normally, with formation of the dorsal liptof the blastopore at the same time as their uninjected siblings.
By stage 11, however, morphological differences are apparent
between injected and uninjected embryos, as tsg MO-injected
embryos appear to close their blastopores at a slower rate than
their uninjected siblings (Figs. 2A, a and g). To see if these
morphological differences were reflected in differences at the
molecular level, we examined the expression of several
markers of dorsal–ventral patterning. At stage 11, the dorsal
organizer markers gsc and chordin are expressed normally in
tsg MO-injected embryos (Figs. 2A, b, h and c, i respective-
ly). However, expression of the prospective muscle marker
myf-5 is greatly reduced (Figs. 2A, d, j), as has been noted
previously in embryos depleted of BMP antagonists (Khokha
et al., 2005). This suggested an early defect in graded dorsal–
ventral identity in tsg-depleted embryos. Consistent with this
hypothesis, expression of the ventral marker sizzled extends
dorsally in tsg-depleted embryos (Figs. 2A, e, k), suggesting a
broader ventrally-specified domain. We find that vent-2
expression is excluded from the organizer in tsg-depleted
embryos as it is in uninjected embryos (Figs. 2A, f, l), but
that vent-2 is consistently expressed through more of the
dorsal animal portion of tsg MO-injected embryos than their
uninjected siblings. Therefore, we find several lines of
evidence to suggest that by mid-gastrulation, tsg-depleted
embryos have a normal organizer, but have defects in dorsal–
ventral patterning consistent with an expansion of ventral
territory.
Because gastrulation is a dynamic process with rapid and
significant changes in gene expression, any slight delay in
development caused by injection of MO might result in the
appearance of substantial fate changes as an artifact of delay.
However, in normal embryos sizzled expression does not begin
until stage 11, and tsg MO-injected embryos not only express
sizzled but show an expansion of this gene marker, suggesting
that changes in other gene expression patterns are not due to
delayed development. In addition, the ventralized phenotype of
Fig. 2. Tsg morphants are ventralized. (A) Embryos were injected at the two-cell stage with a high dose of tsg MO (g– l) and compared to uninjected sibling control
embryos (a– f) at stage 11 for changes in morphology and molecular marker expression as indicated. Arrows in panels e, k indicate the dorsal limit of sizzled
expression, while arrows in panels f, l indicate the animal limit of vent-2 expression. Embryos in panels f, l are shown from a dorsal view, all others are vegetal views
with dorsal to the top. (B) Embryos injected with low (b, f, j, n, r), intermediate (c, g, k, o, s) or high (d, h, l, p, t) doses of tsg MO were compared to uninjected
control siblings (a, e, i, m, q) for changes in morphology and expression of the ventral molecular marker sizzled (e–h, m–p) and the dorsal forebrain marker
eomesodermin (q– t). All embryos are shown in lateral views with dorsal to the top, anterior to the left. Embryos were analyzed at stage 15 (a–h) or stage 25 (i – t).
The arrowhead in panel l marks the cement gland.
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embryos when the dorsal–ventral axis is well-established (see
below).
We then focused our analysis on later stages of develop-
ment. One model for tsg function suggests that tsg can act as a
BMP agonist or antagonist depending on its level of
expression (Larrain et al., 2001). By injecting different doses
of MO, we can deplete endogenous tsg levels to varying
extents and test this hypothesis. We assessed expression of
sizzled as a marker for ventral tissue, and expression of
eomesodermin as a marker for the forebrain, the most dorso-
anterior tissue. At the neurula stage (stage 15), low doses of
the tsg MO have no noticeable effects on morphology
compared to uninjected embryos, or on expression of sizzled
(Figs. 2B, a, b, e, f). By tailbud stage (stage 25), minor
morphological defects become apparent, with 25% of embryos
showing a slight truncation of the anterior/posterior axis and a
subtle expansion of ventral tissue marked by sizzled expres-
sion (Figs. 2B, j, n). Expression of eomesodermin is somewhat
reduced at this dose (Figs. 2B, r), consistent with a reductionin dorso-anterior tissue. At an intermediate dose of tsg MO,
morphological and molecular consequences are more severe.
At stage 15 most embryos still appear wild-type, with a
modest expansion of sizzled expression (Figs. 2B, c, g), but by
stage 25 a clear truncation of the anterior/posterior axis is
evident in all embryos (n = 88), with a markedly reduced head
and an expansion of ventral tissue (Figs. 2B, k, o).
Surprisingly, expression of eomesodermin was lost at this
dose and at higher doses of tsg MO, suggesting a role for tsg
in specification of the forebrain (Figs. 2B, s, t). Other anterior
structures such as the cement gland were not lost at any MO
dose (Figs. 2B, l, arrowhead). This loss of forebrain is
discussed further below (Fig. 4).
The blastopore closure defects suggested by gastrula-stage
embryos injected with a high dose of tsg MO are also reflected
in tailbud-stage embryos injected with an intermediate dose of
MO. 55% of embryos assayed at this stage have incompletely-
closed blastopores. Embryos injected with a high dose of tsg
MO are even more severely affected. 80% of embryos assayed
at stage 15 in this experiment have open blastopores (n = 142)
Fig. 3. Co-injection of tsg mRNA rescues the tsg morphant phenotype. (A) Alignment of the target sequence for the tsg MO used in this study with the 5V region of
mRNAs for X. tropicalis, X. laevis and Oncorhynchus mykiss (rainbow trout). The translational start site is shown in green, mismatches between O. mykiss and the
tsg MO are shown in pink, and mismatches between X. laevis and the tsg MO are shown in blue. (B) Embryos were injected at the two-cell stage with 20 ng tsg MO
or 20 ng tsg MO plus 400 pg of O. mykiss tsg mRNA, then assayed at stage 26 for survival and proper blastopore closure. The experiment was repeated with the
same result. (C) Embryos were injected with 400 pg O. mykiss tsg mRNA (b, f, j, n, r, v), 20 ng tsg MO (c, g, k, o, s, w), or both (d, h, l, p, t, x) and compared to
uninjected sibling control embryos (a, e, i, m, q, u) at stage 11 (a– l), stage 19 (m– t), or stage 26 (u–x) for expression of the molecular markers indicated at left. The
view for each marker is indicated at right. For animal and vegetal views, dorsal is to the top while for ventral and lateral views, anterior is to the left.
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show dramatic upregulation and expansion of sizzled expres-
sion (Figs. 2B, h).
In addition to the expansion of ventral tissues and defects in
blastopore closure, tsg morphants have a decreased rate of
survival. While 100% of embryos survive through gastrulation,
only 40% of embryos injected with this dose of MO survived tostage 25. Those that do survive show severe defects in
blastopore closure, a dramatic reduction in the size of the head
and dorsal structures, a severely truncated anterior/posterior
axis and an expansion of ventral tissue, with a greatly extended
domain of sizzled expression (Figs. 2B, l, p). As shown below,
these defects are specifically due to depletion of tsg and can be
rescued by overexpression of tsg mRNA.
Fig. 4. Forebrain patterning is impaired in tsg morphants. Embryos were
injected with intermediate (B, E, H, K) or high (C, F, I, L) doses of tsg MO and
compared to uninjected sibling control embryos (A, D, G, J). Regional specific
markers of the forebrain were assayed including the dorsal telencephalon
markers eomesodermin (A–C) and emx-1 (D–F), and the ventral telenceph-
alon markers Nkx2.1 (G– I) and Nkx2.4 (J–L). All embryos are shown at stage
23 and are viewed laterally with anterior to the left.
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tissues by morphological and molecular criteria in a dose-
dependent manner. This loss-of-function phenotype is consis-
tent with a reduction in BMP antagonist activity, and is similar
to, but more dramatic than, tsg loss-of-function phenotypes that
have been reported in X. laevis (Blitz et al., 2003; Zakin et al.,
2005). In addition, we find that expression of the ventral
marker sizzled is either unchanged or expanded in embryos
injected with low to high doses of tsg, especially in embryos
that are assayed at later stages of development. We do not find
any evidence for a dorsalized morphology or loss of ventral
marker expression by any dose of tsg MO, in contrast to similar
studies in zebrafish or Xenopus (Little and Mullins, 2004;
Zakin et al., 2005).
To ensure that the phenotypes we observed were specifically
due to the loss of tsg and not to other non-specific
consequences of the MO, we attempted to rescue tsg morphants
by co-injecting embryos with tsg mRNA that was non-
complementary to our MO. We chose rainbow trout (Oncor-
hynchus mykiss) tsg mRNA for this purpose, which encodes a
protein 84% identical to X. tropicalis tsg but does not match
our tsg MO at 10/24 base pair positions (Fig. 3A). We found
that co-injection of 400 pg O. mykiss tsg mRNA with 20 ng
(high dose) of tsg MO resulted in a dramatic improvement in
blastopore closure and survival over embryos injected with tsg
MO alone (Fig. 3B), suggesting that the morphological defects
we observed were due specifically to the loss of tsg gene
product.
We also analyzed expression of several molecular markers
to see if the molecular consequences of the tsg MO were alsorescued by co-injection with tsg mRNA. At mid-gastrula (stage
11), we noted that injection of 400 pg of O. mykiss tsg mRNA
alone resulted in a reduction of sizzled expression, expansion
of myf-5 expression, and expansion of the pan-neural marker
sox-2 relative to uninjected sibling embryos (Figs. 3C, a, b, e, f,
i, j). These changes in molecular marker expression are
consistent with dorsalization, and are complementary to the
effects we observed with tsg MO injection, in which embryos
show expanded sizzled expression, reduced myf-5 expression
and reduced sox-2 expression (Figs. 3C, c, g, k). Co-injection
of tsg mRNA with tsg MO resulted in rescue of the expression
levels of these markers relative to embryos injected with tsg
MO or tsg mRNA alone.
Later molecular consequences of tsg MO injection are also
rescued by mRNA overexpression. At late neurula (stage 19),
expression of the BMP signaling target BAMBI (Onichtchouk
et al., 1999) and of the ventral marker sizzled (Collavin and
Kirschner, 2003) is greatly expanded in embryos injected with
tsg MO compared to uninjected sibling embryos (Figs. 3C, m,
o, q, s). This expansion is rescued by co-injection with tsg
mRNA (Figs. 3C, p, t). The loss of eomesodermin expression
caused by tsg MO injection is also restored by co-injection
with tsg mRNA (Figs. 3C, w, x). Together, these data
demonstrate that embryos in which tsg is overexpressed are
dorsalized, while embryos depleted of tsg are ventralized in a
manner that can be rescued by overexpression of tsg.
Twisted gastrulation is required in forebrain development
The absence of eomesodermin expression in embryos
depleted of tsg suggested a requirement for tsg in the
specification of the forebrain. To characterize this forebrain
defect, we analyzed regional specific markers.
The dorsal telencephalon expresses eomesodermin and
emx1 while the ventral forebrain expresses nkx2.1 and nkx2.4
(Lupo et al., 2002). Injection of an intermediate dose of tsg MO
results in a severe reduction of both dorsal and ventral
telencephalic markers in stage 25 embryos (Fig. 4). Expression
of the dorsal telencephalon marker eomesodermin is absent at
this dose (Fig. 4B), as is expression of the ventral telenceph-
alon marker nkx2.4 (Fig. 4H), while expression of the dorsal
marker emx1 and of the ventral marker nkx2.1 is markedly
reduced (Figs. 4E, K respectively). Emx1 is also expressed in
the developing kidney, and this expression is retained in small
bilateral domains in embryos injected with an intermediate
dose of tsg MO (Fig. 4E, arrowhead). The reduction in
expression is consistent with the finding that the kidney is
induced by anterior somites (Seufert et al., 1999). At a high
dose of tsg MO, expression of all forebrain markers is absent in
stage 25 embryos (Figs. 4C, F, I, L). This loss of forebrain
markers cannot be attributed to a loss of all anterior-most
structures, because ventral–anterior structures such as the
cement gland are retained (Fig. 2). Similarly, the preserved
expression of en-2, krox-20, and otx-2 (Fig. 5, below) indicates
that other markers of brain regionalization are maintained.
Thus, these data demonstrate a requirement for twisted
gastrulation in dorsal and ventral forebrain development.
Fig. 5. Depletion of chordin and tsg reduces dorsal tissues and results in a cooperative expansion of ventral tissues. Embryos were injected at the two-cell stage with
tsg MO (B, F, J, N, R, V, Z, DD), chordin MO (C, G, K, O, S, W, AA, EE), or both MOs (D, H, L, P, T, X, BB, FF) and compared to uninjected sibling control
embryos (A, E, I, M, Q, U, Y, CC). Embryos were assayed for expression of the ventral markers BAMBI (E–H) and sizzled (I –L) and the somite markermyoD (M–P).
Embryos were also assayed for expression of several regional specific markers of the neural plate: eomesodermin (Q–T), otx2 (U–X), en-2 (Y–BB) and krox-20
(CC–FF). All embryos are between stages 22–25. Embryos stained for expression ofmyoD (M–P) and krox-20 (CC–FF) are viewed dorsally with anterior to the left,
all others are viewed laterally with anterior to the left.
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A central goal of this study was to establish whether tsg
behaves as a BMP agonist or antagonist in the context of
normal Xenopus tropicalis development. If tsg is a BMP
antagonist that cooperates with the known BMP antagonist
chordin, one would predict that loss of tsg function would
augment the chordin loss of function phenotype. We therefore
co-injected MOs directed against tsg and chordin and assayed
their combined effects on development. The chordin MO
causes a ventralized phenotype characterized by a reduction inhead size and expansion of ventral tissue similar to the
phenotype seen in X. laevis (Fig. 5C) (Oelgeschlager et al.,
2003a). At the tailbud stage, embryos co-injected with these
two morpholinos showed severe ventralization and loss of
dorsal structures (Fig. 5D). The head is reduced and the
anterior/posterior axis is dramatically shortened. Co-injection
of both MOs results in severe defects in blastopore closure
(95% open blastopores at stage 25, n = 183) and a pronounced
expansion of ventral tissue as compared to dorsal tissue. These
phenotypes are more frequent and severe in co-injected
embryos than in embryos injected with either MO alone.
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(Blitz et al., 2003), and are consistent with the hypothesis that
tsg acts as a BMP antagonist and acts cooperatively with
chordin.
Since dorsal–ventral patterning is dependent on a proper
balance of BMP signaling, reduction of BMP antagonists
should lead to a reduction in dorsal cell fates and to an
expansion of ventral cell fates. To ascertain if tsg cooperates
with chordin to expand ventral tissues, we assayed BAMBI and
sizzled. These markers were notably expanded in embryos
injected with tsg or chordin MOs (Figs. 5E–L). Expression of
both BAMBI and sizzled is dramatically increased in embryos
co-injected with both tsg and chordin MOs (Figs. 5H, L). In
these co-injected embryos, the vast majority of the embryo is
converted to ventral tissue, with the exception of a narrow
domain at the extreme dorsal edge that retains a dorsal fate.
These data strongly suggest that tsg and chordin act cooper-
atively to generate normal patterning along the dorsal–ventral
axis, since reduction of both proteins leads to more dramatic
ventralization than the loss of either protein individually.
Embryos injected with tsg and chordin MOs also show
reduced expression of dorsal markers. The somite marker
myoD is reduced in intensity and the volume of myoD-
positive tissue in embryos injected with each MO and both
MOs (Figs. 5M–P), consistent with the reduction in myf-5
expression seen in younger embryos. To characterize ante-
roposterior patterning of the neural plate, we assayed otx2
(anterior), engrailed-2 (midbrain–hindbrain border), and
krox-20 (hindbrain) expression, which were all slightly
reduced in late neurula-stage embryos injected with interme-
diate amounts of tsg MO or chordin MO, and were also
reduced but not lost in embryos co-injected with both MOs
(Figs. 5U–FF). The boundaries of en-2 and krox-20 retain
their relative anterior/posterior positions. At tailbud stages,
expression of the forebrain marker eomesodermin was usually
lost in embryos injected with either tsg MO (83%, n = 24) or
chordin MO (89%, n = 18) alone, and was always lost in
embryos injected with both MOs (Figs. 5Q–T), suggesting
that chordin is also required for specification of the forebrain,
and that high levels of BMP antagonism are generally
required to establish forebrain tissue. We conclude that
depletion of tsg and chordin results in reduction of regional
markers of the neural plate and in a loss of forebrain. We find
that loss of chordin and tsg, whether individually or together,
always results in an overall reduction of dorsal structures and
expansion of ventral structures, with a cooperative ventraliz-
ing effect when both gene products are knocked down. We
find no evidence for a rescue of the chordin loss-of-function
phenotype by tsg depletion, as would be expected if tsg
inhibited chordin activity, but conclude rather that tsg and
chordin act cooperatively as BMP antagonists in the context
of embryonic development.
Rescue of tsg with knockdown of BMPs
Knockdown of tsg and chordin results in a more severe
expansion of ventral tissues than knockdown of either geneproduct alone, strongly suggesting that tsg acts as a BMP
antagonist during development. BMP antagonists maintain a
precise regulation of BMP signaling across the dorsal–ventral
axis. According to this model, if BMP antagonists are
depleted, the balance of BMP signaling should be regained
by a compensating depletion of BMPs. A phenotype
generated by knockdown of a BMP antagonist should thus
be rescued by depletion of BMPs (Khokha et al., 2005). We
confirmed the effectiveness of this strategy in this context by
reducing BMP4 and BMP7 gene products to rescue the
effects of chordin MO injection in tailbud-stage embryos
(Supplementary Fig. 1). Co-injection of the BMP MOs in this
manner rescues the reduction in head size and loss of
eomesodermin expression seen in chordin MO-injected
animals (78%, n = 45). Expression of sizzled is also reduced
to wild-type levels.
We then investigated whether the tsg knockdown phenotype
could be similarly rescued by co-injection with BMP MOs. Tsg
has been shown to interact biochemically with both BMP4 and
BMP7 (Oelgeschlager et al., 2000; Zakin and De Robertis,
2004; Zakin et al., 2005). We injected an intermediate dose of
tsg MO, which causes a severely ventralized phenotype (Fig. 2),
with varying doses of BMP4 and BMP7 MOs. Fig. 6A shows
that co-injection of tsg MO with BMP MOs results in a
significant improvement in blastopore closure. A combination
of tsg MO injected with 40 ng of either BMP4 or BMP7 MO or
with 20 ng of both BMP4 and BMP7 MOs results in 30–40%
more closed blastopores in stage 25 embryos than in embryos
injected with tsg MO alone. Injection of BMP MOs alone had
no effect on blastopore closure.
Embryo morphology was also rescued by co-injection of
BMP MOs with tsg MO, as shown in Fig. 6B. Co-injecting 40
ng of BMP4 MO with an intermediate dose of tsg MO resulted
in 85% of embryos showing at least some rescue of head size
and length of the anterior/posterior axis, with 37% of embryos
showing extensive rescue of these features and a nearly-
wildtype morphology, including reduced ventral tissue and
wild-type tailbud morphology. Similar results were seen for co-
injection of 40 ng BMP7 MO with tsg MO. An even more
dramatic rescue effect was seen in embryos co-injected with tsg
MO and 20 ng of both BMP4 and BMP7 MOs. 96% of these
embryos showed some morphological rescue, and 74% have
extensive rescue of head morphology, length of the A/P axis,
and amount of ventral tissue. At these doses, injection of BMP
MOs alone had modest effects on embryo morphology
(Supplementary Fig. 2), although at higher doses, we do
observe phenotypes similar to those previously reported
(Reversade et al., 2005).
Our finding that BMP knockdown effectively rescues the
tsg MO phenotype again supports the hypothesis that tsg acts
as a BMP antagonist in the context of X. tropicalis gastrulation.
BMP knockdown rescues forebrain and ventral mesoderm in
embryos depleted of tsg
To characterize the extent of rescue caused by co-injection
of BMP MOs with tsg MO in more detail, we examined the
Fig. 6. BMP depletion rescues tsg morphants morphologically. (A) The
incidence of blastopore closure was quantified in embryos injected at the two-
cell stage with tsg MO, BMP MOs, or varying combinations of tsg and BMP
MOs as indicated. The experiment was repeated with similar results. (B) Co-
injection of tsg MO with BMP MOs rescues embryos morphology to varying
extents. Embryos were injected at the 2-cell stage with 10 ng of tsg MO and
either 40 ng of BMP4 MO, 40 ng of BMP7 MO, or 20 ng of both BMP4 and
BMP7 MOs. For each combination, the percentage of embryos observed with
each degree of rescue was quantified. Representative embryos for each category
of rescue are included at right. The category represented in blue indicates
embryos with minimal or no rescue of head morphology or embryo length.
Embryos represented by the red category had mild to moderate rescue of head
morphology and/or embryo length. Embryos represented by the yellow
category showed significant rescue of head morphology, embryo length and
overall morphology. For panels A and B, all embryos were injected at the 2-cell
stage with the combination of MOs indicated, and were assayed at stage 25 for
blastopore closure and morphology.
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mesodermal markers. Given the loss of forebrain tissue in
embryos depleted of tsg, we analyzed two forebrain markers,
eomesodermin and xbf-1. Forebrain expression of both
markers is rescued by co-injection with BMP 4 and 7 MO
(Fig. 7, compare T, X to R, V). The expression of krox-20 is
also restored to wild-type levels by co-injection with BMP
MOs (Figs. 7J, L). Expression of the midbrain–hindbrain
boundary marker en-2 and of the posterior spinal chord
marker HoxB9 is unaffected by either tsg or BMP MOs, and
these markers retain their relative anterior/posterior bound-
aries (Figs. 7F–H). The expression patterns of these dorsal
markers in embryos injected with only BMP4 and 7 MOs are
similar to uninjected embryos (Figs. 7G, K, O, S, W).
Ventral markers are also restored to wild-type levels by co-
injection of tsg MO with BMP 4 and 7 MOs. The ventral
marker sizzled, which is substantially expanded by tsg MOinjection (Fig. 7Z), is rescued to wild-type levels by co-
injection with BMP 4 and 7 MOs (Fig. 7BB). The expression
of sizzled in embryos injected with a low dose of either BMP
4 or BMP 7 MOs alone is similar to wild type (Fig. 7AA).
However, expression of sizzled and of BAMBI is reduced
when high doses of BMP4/7 MOs are injected (data not
shown).
Rescue of tsg with chordin mRNA
To test our hypothesis that tsg acts as a BMP antagonist
further, we attempted to rescue the intermediate tsg phenotype
with a dose of chordin mRNA that is sufficient to induce
secondary axes (Larrain et al., 2000). Co-injection of chordin
mRNA in tsg MO-injected embryos results in a dorsalized
morphology characterized by a large head and truncated
anterior/posterior axis (Fig. 8C). The frequency of blastopore
closure defects (18.8%, n = 32), is reduced in embryos co-
injected with chordin mRNA as compared with embryos
injected with tsg MO alone (59%, n = 88). This rescue of
blastopore closure is comparable to that achieved by co-
injecting tsg MO with BMP4 and BMP7 MOs (Fig. 6A: 85%
closed blastopores, n = 99). Secondary axes are occasionally
observed in late tailbud stage embryos injected with tsg MO
and chordin mRNA (15%, n = 32), but at a reduced
frequency from embryos injected with chordin mRNA alone
(28%, n = 38). Expression of sizzled is restored to wild-type
levels in embryos co-injected with tsg MO and chordin
mRNA (Figs. 8A–C). Expression of eomesodermin is also
recovered in these embryos (Figs. 8D–F). This recovery of
marker expression supports our prediction that loss of tsg
function can be rescued by chordin mRNA, consistent with
the hypothesis that tsg and chordin work collaboratively as
BMP antagonists.
Discussion
Tsg is required for forebrain development in X. tropicalis
We have found that reduction in tsg function results in a
complete loss of dorsal and ventral forebrain marker
expression at tailbud stages. This loss is specific to the
forebrain and does not reflect a general loss of anterior
structures, since the cement gland, another anterior structure,
is preserved. Neither can this loss of forebrain be attributed to
a failure of brain differentiation or specification in general,
since other markers for midbrain and hindbrain such as
engrailed and krox-20 are preserved with only a slight
reduction in the domain of expression. Otx-2, which marks
both the forebrain and the midbrain, is reduced but not lost,
and based on the loss of expression of all markers specific to
the forebrain, we suggest that the remaining Otx-2 expressing
tissue has midbrain identity. The absence of forebrain marker
expression seen in tsg morphants is rescued by reducing BMP
signaling through knockdown of BMP4 or BMP7, and by
overexpression of the BMP antagonist chordin, indicating that
forebrain specification requires adequate BMP antagonism. A
Fig. 7. BMP depletion rescues patterning defects in tsg morphants. Expression of region-specific markers were analyzed at stage 25 in uninjected embryos (A, E, I,
M, Q, U, Y), and in embryos injected with 10 ng of tsg MO (B, F, J, N, R, V, Z), 20 ng each of BMP4 and BMP7 MOs (C, G, K, O, S, W, AA) or a combination of
10 ng tsg MO and 20 ng of BMP4 and BMP7 MOs (D, H, L, P, T, X, BB). Markers assayed included the midbrain–hindbrain boundary marker en-2 (E–H), the
hindbrain marker krox-20 (I –L), the spinal cord marker hoxb 9 (M–P), the forebrain markers Xbf-1 (Q–T) and eomesodermin (U–X) and the ventral marker sizzled
(Y–BB). All views are lateral with anterior to the left and dorsal to the top.
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has been described in the mouse (Bachiller et al., 2000), and
we also find that loss of chordin function results in loss of
forebrain marker expression, which is recovered by simulta-
neous loss of BMPs. The requirement for tsg in specifying theFig. 8. Chordin overexpression rescues tsg morphants. Expression of the ventral mes
in sibling embryos injected with intermediate doses of tsg MO (B), or an intermedi
telencephalon marker eomesodermin was also compared among uninjected embryo
siblings injected with an intermediate dose of tsg MO and chicken chordin mRNAforebrain can be compensated by overexpression of chordin.
Thus, our findings support a model in which the biochemical
interaction between tsg and chordin results in a potentiation
of chordin function, and that in the absence of tsg, more
chordin is required to achieve proper patterning of theodermal marker sizzled was examined in stage 25 uninjected embryos (A), and
ate dose of tsg MO plus chicken chordin mRNA (C). Expression of the dorsal
s (D), sibling embryos injected with an intermediate dose of tsg MO (E), and
. All views are lateral with anterior to the left and dorsal to the top.
A. Wills et al. / Developmental Biology 289 (2006) 166–178176forebrain. It is also possible that the BMP binding activity of
tsg allows it to act as a BMP antagonist independently of
chordin, and that tsg and chordin act additively and indepen-
dently to specify the forebrain. A specific requirement for tsg in
specifying the forebrain has not been previously demonstrated.
In one mouse study, genetic knockouts of tsg cause
craniofacial defects and loss of head structures (Petryk et
al., 2004), but these effects are restricted to particular genetic
backgrounds and were not described in other mouse loss-of-
function studies (Nosaka et al., 2003) except in the
compound tsg mutant and BMP4 heterozygote (Zakin and
De Robertis, 2004). Thus we show that the BMP antagonist
activity of tsg is required for the development of the
forebrain in Xenopus.
Twisted gastrulation is a BMP antagonist in the Xenopus
gastrula
The activity of twisted gastrulation has been controversial.
While there is ample biochemical evidence for a direct
interaction between tsg, BMPs and chordin, the in vivo role
of tsg has been more difficult to establish with certainty.
Because of the apparent contradiction among overexpression
studies (Oelgeschlager et al., 2000; Scott et al., 2001), it has
been suggested that low doses of twisted gastrulation protein
might result in BMP antagonist-like activity while high doses
promote the release of BMPs from chordin, thus potentiating
BMP signaling. Here, we report that the activity of twisted
gastrulation with respect to BMP signaling is exclusively
antagonistic in the context of X. tropicalis gastrulation.
Titration of the tsg MO reveals a dose-dependent increase
in ventral cell fates by morphological and molecular criteria,
with reduction of dorso-anterior structures and extensive
expansion of ventral mesoderm. At no dose of MO do we
observe any evidence for dorsalization. This argues against a
model where tsg can have both BMP agonist and BMP
antagonist roles depending on concentration, at least at
physiological levels within the gastrulating embryo. Instead
we favor a role for strict BMP antagonism in the context of
early X. tropicalis development. Our analysis of mid-gastrula
stage tsg morphants reveals that ventral territory is already
expanded while prospective neural tissue is reduced, indicat-
ing that tsg acts as a BMP antagonist during gastrulation
when these tissues are first being specified. The high levels of
zygotic expression of tsg in the ventral tissues of tailbud-stage
embryos suggest that it may also have a role in maintaining
repression of BMP signaling activity later in development.
Overexpression of tsg leads to opposite phenotypes, namely
an increase in neural tissue and decrease in ventral tissue, and
can also rescue the patterning defects seen in tsg depleted
embryos. We note that the morphology of embryos co-
injected with tsg MOs and BMP MOs is more nearly wild-
type than that of embryos co-injected with tsg MO and tsg
mRNA. We take this as evidence that the depletion approach
offered by concurrent MO injection results in more nearly
physiological levels of BMP signaling than can be achieved
by combined knockdown and overexpression of tsg, whichmay be complicated by non-physiological timing or location
of tsg overexpression.
Our loss of function evidence demonstrates that tsg is a
crucial molecule in X. tropicalis development. Depletion of
tsg, results in multiple phenotypes in gastrula, neurula, and
tailbud-stage embryos: loss of the forebrain, reduction in
dorsal tissues, expansion of ventral tissues, and gastrulation
defects as evidenced by open blastopores and resultant loss of
viability. While not a focus of the present study, blastopore
closure defects represent another specific phenotype in tsg-
depleted embryos. Many of these defects are exacerbated by a
simultaneous loss of chordin. Importantly, the morphological
and molecular phenotypic characteristics of tsg knockdown
can all be rescued by a controlled loss of BMPs or increase of
chordin, collectively supporting a cooperative interaction
between chordin and tsg and opposing BMP signaling. The
tsg loss of function phenotype described here for X. tropicalis
and elsewhere for X. laevis is more severe than that caused by
genetic knockouts in mice or MO-based knockdown in
zebrafish (Blitz et al., 2003; Little and Mullins, 2004; Nosaka
et al., 2003; Petryk et al., 2004; Scott et al., 2001; Zakin and
De Robertis, 2004), and suggests that tsg is particularly
crucial for regulating BMP signaling in Xenopus species.
Our evidence for tsg function in X. tropicalis supports
other MO-based loss of function experiments conducted in X.
laevis (Blitz et al., 2003). However, another recent report in
X. laevis describes a contrasting finding: that injection of a
tsg MO results in reduced expression of the ventral marker
sizzled in late gastrula stage embryos, which is further
reduced by co-injection of a BMP7 MO (Zakin et al.,
2005). This is in sharp contrast to the findings in this study.
The reason for this discrepancy is uncertain. One possibility is
the difficulty of achieving consistent gene product knock-
down in the allotetraploid X. laevis. Polymorphisms and the
effects of gene copy number can affect morpholino binding
and consequent phenotypic effects, which has been reported
for X. laevis (Khokha et al., 2002; Piepenburg et al., 2004).
Because X. tropicalis is inbred and has a diploid genome,
designing effective MOs is simplified. Our data demonstrate a
dramatically ventralized phenotype in tsg knockdown embryos
with consistent expansion of ventral markers and loss of
dorso-anterior markers at several doses of tsg MO, and we
find no evidence for dorsalization by loss of tsg. These
morphological and molecular consequences of tsg knockdown
can be rescued both by loss of BMP gene product and by
overexpression of chordin, demonstrating the specificity of
these phenotypic effects, which are clearly consistent with a
role for tsg as a BMP antagonist rather than an enhancer of
BMP function.
Our data also contrast with conclusions drawn from recent
loss-of-function experiments in zebrafish that argue in favor of
a role for tsg in promoting BMP signaling (Little and Mullins,
2004; Xie and Fisher, 2005). However, in early patterning of
the zebrafish, the role of tsg has also been controversial, with
an earlier report suggesting that depletion of tsg results in a
phenotype indicative of a BMP antagonist (Ross et al., 2001).
A remaining possibility to reconcile the differences in loss-of-
A. Wills et al. / Developmental Biology 289 (2006) 166–178 177function analyses of tsg in frogs and zebrafish is that at the
biochemical level, tsg can act both as a BMP agonist
(competing with chordin for BMP binding) and antagonist
(strengthening the association between chordin and BMPs),
and that this duplicity of roles is exploited differently in
different animals. Our data demonstrate an exclusive function
for tsg in cooperating with chordin to antagonize BMP
signaling in the X. tropicalis gastrula, and suggest that though
tsg may be biochemically plastic, its in vivo role in this system
is restricted to BMP antagonism.
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